Indicated for: protection against chemotherapy or radiotherapy toxicity
Route of administration: injectable
Substance: dexrazoxane (antidote)
ATC: V03AF02 (Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment)
Dexrazoxane is a medication used to protect against anthracycline-induced cardiotoxicity, a type of chemotherapy used in cancer treatment. It works by chelating iron ions, reducing the formation of free radicals that can damage the heart muscle.
The medication is administered intravenously, usually before anthracycline administration, under the supervision of an oncologist.
Side effects may include nausea, vomiting, decreased blood cell counts, or injection site reactions. In rare cases, severe allergic reactions may occur.
Patients should be closely monitored during treatment, and pregnant or breastfeeding women should consult a specialist before use.